The Peptide Synthesis Market, valued at USD 597.3 Million in 2023, is anticipated to surpass USD 1,173.0 Million by 2032, reflecting a projected CAGR of 7.9%

The peptide synthesis market is growing steadily due to rising demand for peptide-based treatments in a variety of medical sectors, including oncology, metabolic disorders, and infectious illnesses. Technological advances in solid- and liquid-phase synthesis techniques have improved efficiency and cost-effectiveness, moving the sector forward. Furthermore, peptides are gaining popularity in the cosmetics, agriculture, and food industries due to their useful qualities.

However, challenges such as high production costs, sophisticated purification procedures, and stringent regulatory restrictions stymie industry growth. The pharmaceutical industry is the most important end user, with customized medicine and biologics boosting peptide demand. Furthermore, contract research and manufacturing organizations (CROs and CMOs) are rapidly outsourcing peptide synthesis services, which are fueling market expansion. North America dominates the market due to large R&D spending, however Asia-Pacific is emerging as a key rising region due to increased biopharmaceutical research and the availability of low-cost manufacturing facilities.

Peptide Synthesis Market Statistics

• The global peptide synthesis market was valued at USD 597.3 Million in 2023
• The market is projected to increase at a stable annual pace of 7.9% from 2024-2032
• North America accounts for 38% of the peptide synthesis market
• Asia-Pacific is growing at a CAGR of 8.6% within the peptide synthesis market
• The liquid phase peptide synthesis technology has the largest earning peptide synthesis market
• The peptide synthesis market has seen significant revenue growth from therapeutics application
• The peptide synthesis market is experiencing a trend of increasing applications of peptides in cosmetics, agriculture, and food industries

Request For a Free Sample of This Premium Research Report

Peptide Synthesis Market Dynamics

Rising Adoption of Peptide-Based Therapeutics Drivers the Peptide Synthesis Market

The increasing adoption of peptide-based therapeutics is a primary driver propelling the peptide synthesis market. Peptides have demonstrated high specificity, low toxicity, and excellent efficacy in treating a range of diseases, particularly in oncology, metabolic disorders, and infectious diseases. The pharmaceutical industry is witnessing a surge in peptide-based drug approvals, with major companies investing heavily in research and development. Moreover, advancements in peptide synthesis technologies, including solid-phase and hybrid-phase methods, have streamlined the production process, making large-scale manufacturing more efficient. The shift towards biologics and personalized medicine has further accelerated peptide adoption, as they offer targeted therapeutic benefits with minimal side effects. Additionally, the rising demand for synthetic peptides in vaccine development, particularly for infectious diseases like COVID-19, has further boosted market growth. Despite challenges such as regulatory hurdles and production costs, the increasing therapeutic applications of peptides continue to drive market expansion.

Expansion of Peptides in Non-Pharmaceutical Applications Offers Opportunities in the Peptide Synthesis Market

While pharmaceuticals dominate peptide synthesis applications, a significant opportunity lies in expanding peptide use in non-pharmaceutical industries such as cosmetics, agriculture, and food technology. In the cosmetics industry, bioactive peptides are increasingly incorporated into skincare products due to their anti-aging, anti-inflammatory, and collagen-boosting properties. Meanwhile, in agriculture, peptides are being developed as environmentally friendly bio-pesticides and plant growth regulators, offering a sustainable alternative to chemical fertilizers. Additionally, the food industry is utilizing peptides for their functional properties, such as enhancing flavors, improving texture, and providing nutritional benefits. With growing consumer preference for natural and bio-based ingredients, the demand for synthetic peptides in these sectors is expected to rise. Companies are investing in research to develop cost-effective and scalable peptide production methods, which will further drive adoption. The diversification of peptide applications beyond healthcare presents a lucrative growth avenue for manufacturers and research institutions.

Product and Technology Insights

Convergent synthesis involves the independent synthesis of the peptide sequences, which are connected in the liquid phase by condensation. Many checks must be performed during the peptide synthesis cycle at medium, but mostly to the final product. The ninhydrin test is the most common test of free amino groups due to its tolerance and reproducibility. Enzymes are the cell activation biology catalysts. As such, they need to perform well under the mild cell operating conditions. They must be robust enough to meet harsh conditions of an industrial process, usually involving modification of the enzyme to produce a stable biocatalyst, to become process biocatalysts.

Extensive studies aimed at producing new equipment for peptide synthesis have contributed to this segment's most rapid growth in the global market. The term solid phase peptide synthesis is misleading and gel-phase synthesis is more suitable. In the coming years, recent developments concerning peptide coupling reagents are expected to boost market growth.

Peptide Synthesis Market Segmentation

The worldwide peptide synthesis market is divided into 5 segments: product, technology, application, end use, and regional markets

• Product: equipment, reagents & consumables, and services
• Technology: liquid phase peptide synthesis (LPPS), solid phase peptide synthesis (SPPS), and hybrid technology
• Application: therapeutics, research, and diagnosis
• End use: pharmaceutical & biotechnology companies, academic & research institutes, and contract development & manufacturing organization/contract research organization
• Regional: the Middle East & Africa, Asia-Pacific, Europe, Latin America, and North America

Peptide Synthesis Market Regional Outlook

The peptide synthesis market exhibits strong regional variation, with North America leading due to its well-established biopharmaceutical industry, significant R&D investments, and advanced manufacturing infrastructure. The presence of key players, along with increasing government funding for peptide-based drug development, further strengthens the region's dominance. Europe follows closely, with a growing focus on peptide therapeutics, particularly in oncology and metabolic diseases. Stringent regulatory frameworks and strong academic research collaborations contribute to market growth in the region.

Asia-Pacific is emerging as the fastest-growing market, driven by increasing biopharmaceutical research, rising healthcare investments, and a cost-effective manufacturing landscape. Countries like China, India, and South Korea are expanding their peptide synthesis capabilities to cater to the growing demand from pharmaceutical and biotechnology companies. Latin America and the Middle East & Africa hold a smaller market share but are witnessing gradual growth due to increasing pharmaceutical investments and improving healthcare infrastructure.

Peptide Synthesis Market Players

Peptide synthesis companies profiled in the report includes PuroSynth, Biotage, Thermo Fischer Scientific, Inc., Syngene, CEM Corporation, MP Biomedicals, Novo Nordisk A/S, Bachem Holdings AG, Creative Diagnostics, Merck KGaA, Polypeptide Group, and Lonza.

Purchase This Premium Research Report Now!

Peptide Synthesis Market Key Insights

Mr. Richard Johnson

Acumen Research and Consulting

India: +91 8983225533

E-mail: [email protected]